Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Stockholders Equity of -$94.49 million for fiscal year 2024.
NORTHWEST BIOTHERAPEUTICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$94.49M | -43.7% |
| 2023 | -$65.77M | +48.7% |
| 2022 | -$128.10M | -3.3% |
| 2021 | -$123.99M | +65.8% |
| 2020 | -$362.95M | -705.6% |
| 2019 | -$45.05M | +6.4% |
| 2018 | -$48.13M | +28.5% |
| 2017 | -$67.33M | -154.1% |
| 2016 | -$26.50M | -466.7% |
| 2015 | -$4.68M | +86.7% |
| 2014 | -$35.03M | -256.8% |
| 2013 | -$9.82M | +38.9% |
| 2012 | -$16.07M | +69.2% |
| 2011 | -$52.17M | -88.5% |
| 2010 | -$27.68M | -33.8% |
| 2009 | -$20.69M | -68.2% |
| 2008 | -$12.30M | -311.8% |
| 2007 | $5.81M | +197.6% |
| 2006 | -$5.95M | +47.9% |
| 2005 | -$11.42M | -118.9% |
| 2004 | -$5.22M | -34880.0% |
| 2003 | $15.0K | -99.7% |
| 2002 | $4.88M | -71.2% |
| 2001 | $16.93M | +175.2% |
| 2000 | -$22.52M | -52.2% |
| 1999 | -$14.79M | -60.4% |
| 1998 | -$9.22M | -120.9% |
| 1997 | -$4.17M | -211.7% |
| 1996 | -$1.34M | — |
| 1996 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$108.65M | -35.6% | -8.2% |
| June 30, 2025 | -$100.39M | -31.2% | -0.9% |
| March 31, 2025 | -$99.48M | -35.7% | -5.3% |
| December 31, 2024 | -$94.49M | -43.7% | -17.9% |
| September 30, 2024 | -$80.12M | -14.4% | -4.7% |
| June 30, 2024 | -$76.50M | -25.3% | -4.4% |
| March 31, 2024 | -$73.28M | -30.9% | -11.4% |
| December 31, 2023 | -$65.77M | +48.7% | +6.1% |
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -43.7% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from NORTHWEST BIOTHERAPEUTICS INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: